A Strong Start: Plasma Glial Fibrillary Acidic Protein and Stroke Differential Diagnosis | Zendy

J.P. Mohr | Zendy; Julia Kejda-Scharler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Strong Start: Plasma Glial Fibrillary Acidic Protein and Stroke Differential Diagnosis

Author(s) -

J.P. Mohr,

Julia Kejda-Scharler

Publication year - 2011

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2011.177501

Subject(s) - glial fibrillary acidic protein , stroke (engine) , differential (mechanical device) , differential diagnosis , gfap stain , chemistry , medicine , pathology , immunohistochemistry , physics , thermodynamics

In the January issue of Clinical Chemistry , Foerch and colleagues (1) report on the diagnostic accuracy of plasma glial fibrillary acidic protein (GFAP)2 for differentiating intracerebral hemorrhage (ICH) and cerebral ischemia in patients with symptoms of acute stroke. This major, welcome effort from the Biomarker for Rapid Diagnosis of Hemispheric Stroke (BE FAST!) group cites highly significant differences in plasma GFAP collected within 4.5 h of symptom onset for acute stroke. No fewer than 14 centers (13 German and 1 Swiss) collected data on 205 patients during the 1-year period between June 1, 2009, and May 31, 2010. The diagnostic accuracy for ICH generated P values of <0.001, compared with ischemic stroke (IschSt) or stroke “mimic.”A readily performed blood test that showed this large a difference would affect the management of acute stroke. It could spare the lost time and efforts of acute imaging tests to rule out ICH and …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research